<DOC>
	<DOCNO>NCT01180296</DOCNO>
	<brief_summary>To evaluate whether daily oral micronized progesterone effective preventing recurrent spontaneous preterm birth ( RSPB ) whether micronized progesterone use increase maternal serum progesterone level .</brief_summary>
	<brief_title>Oral Progesterone Prevention Preterm Birth</brief_title>
	<detailed_description>To evaluate whether 400 mg daily oral micronized progesterone 16 34 week ' effective prevent recurrent spontaneous preterm birth ( RSPB ) whether micronized progesterone use increase maternal serum progesterone level .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>pregnant woman le 20 week ' gestation least one prior spontaneous preterm birth liveborn baby 20 &amp; 0/7 week ' 36 &amp; 6/7 week ' gestation . multiple gestation , presence major fetal anomaly , progesterone use current pregnancy ( ongoing past ) , presence cervical cerclage , presence placenta previa .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Preterm birth , prevention , progesterone , oral</keyword>
</DOC>